Husband and wife team say cancer vaccine could be available for patients within the next decade
Husband and wife team behind Pfizer-BioNTech Covid jab says patients could have access to cancer vaccines within the next decade
- Cancer treatment could be available for patients by 2030, husband and wife team say
- German professors Ozlem Turech and Ugur Shahin find a ‘breakthrough’
- Tulesi: ‘Cure cancer, or change the lives of people with cancer, is in our hands’
- They used mRNA technology to develop a Pfizer/Biontech vaccine for Covid-19
A cancer cure is within reach and could be available to patients by 2030, says the husband and wife team behind one of the most successful Covid jabs .
German professors Ozrem Turech, 55, and Ugur Sahin, 57, say scientists are hesitant to say they have a cure for cancer, but they have a “breakthrough” that will keep them going. said to have found
Professor Tulesi said:
The couple co-founded BioNTech in Mainz, Germany in 2008, pioneering personalized cancer immunotherapy and developing the Pfizer/BioNTech Covid vaccine.
They spoke on the BBC’s Sunday program this morning about their hopes for cancer treatment on Laura Kensberg’s show.
Asked when many patients around the world will have access to cancer vaccines, Professor Sahin said, “By 2030, we believe this will happen, even on a broader scale.” .
“As a scientist, I don’t want to say that we can develop a cure for cancer,” Professor Tulesi warned, adding:
They said the development and success of the Pfizer/Biontech vaccine against Covid-19, which was widely deployed in the pandemic, aided their work in finding a cure for cancer.
The couple was interviewed on BBC’s Laura Kensberg program on Sunday.
They described development and success of Pfizer/BioNTech vaccine against Covid-19
The couple said their use of mRNA technology was revolutionary in the fight against Covid-19, and their success has been both impactful and beneficial.
Professor Tuleti told Kuensberg, “Decades of development for cancer vaccine development have been a tailwind for the development of a Covid-19 vaccine, and now the Our experience feeds back into our cancer research.
“We have learned how to make vaccines better and faster. We have learned how the immune system responds to mRNA in many people.
“This will definitely accelerate our cancer vaccines as well,” she added.
Conventional vaccines are manufactured using attenuated viruses, but the mRNA uses only the viral genetic code.
Conventional vaccines are manufactured using attenuated viruses, but the mRNA uses only the viral genetic code.
An mRNA vaccine is injected into the body where it enters cells and tells them to make antigens. Antigens are recognized by the immune system and prepared to fight disease.
Professor Tulesi said the development has also helped regulators learn about mRNA vaccines and how to deal with them.
Tureci, who has worked in the field for 30 years, admitted that nature and biology hold “so many secrets” that the couple will continue to navigate.
Moderna said in August it was suing BioNTech and its partner US pharmaceutical giant Pfizer for patent infringement on the company’s Covid-19 vaccine.
“Every patient we treat in a cancer trial helps us know what their opposition is and how to deal with it,” she said.
Moderna announced in August that it was suing BioNTech and its partner, US pharmaceutical giant Pfizer, for infringing patents on the company’s Covid-19 vaccine.
When asked about the lawsuit, Professor Sahin said: We’ve spent his 20 years developing this kind of therapy, and of course we’re going to fight for our intellectual property. ”
Ugur Sahin and Ozrem Tulechi: Husband and wife ‘dream team’ behind coronavirus vaccine
Doctors Ugur Sahin and Ozlem Tureci are the husband and wife ‘dream team’ behind the groundbreaking Covid-19 vaccine that will soon be rolled out across the UK.
The UK was the first country in the world to approve the vaccine, which has been shown to be 95% effective and effective in all age groups.
BioNTech CEO Professor Sahin worked with his wife and the company’s chief medical officer, Dr. Tureci, to develop Jab.
The couple are said to be worth billions, but Professor Sahin reportedly still bikes to work
BioNTech began preparing for the coronavirus in January after Professor Sahin read an article in a medical journal that convinced him the virus would escalate into a full-blown pandemic.
Founded just 12 years ago, BioNTech has teamed up with the 171-year-old pharmaceutical giant, Pfizer.
Professor Sahin came to Germany from Turkey when he was four years old. He graduated from the University of Cologne in 1990 with his Ph.D.
Dr. Tureci, also from Turkey, received his M.D. from Saarland University Medical School, Homburg, Germany and is currently President of the Cancer Immunotherapy Association.
Bound by a shared love of medical research and oncology, the couple founded BioNTech in 2008 with the goal of pursuing a wider range of cancer immunotherapy tools.
According to reports, on their wedding day in 2002, the pair only temporarily left lab work to attend a registry office.
The couple is said to be worth billions, but Professor Sahin reportedly still bikes to work.
advertisement
